Anjali B Saxena, MD
Nephrology · San Jose
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Probation Completed
- 2 Medical Board actions on record
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: 052305 · 552767 · Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Saxena’s office at (408) 885-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A67175 · Current
Licensed to practise in California · since 1998 · expires 2028-12-31 · Bowman Gray School of Medicine of Wake Forest University. Board flags: Probation Completed, Misdemeanor Conviction.
Public record actions
| 2026-05-18 | Board disciplineDiscipline | Probation completed. · 8002024110191 |
| 2021-03-08 | Misdemeanor convictionDiscipline | Pled NO contest to violating penal code section 273A(A) (child endagerment) and vehicle code section 23103(A) (reckless driving). · Superior court of california, county of santa clara · Pending. |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$83,349
Medicare paid this office $83,349 for 139 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $24,563 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $13,888 | $107 |
| Return visit (30+ min) | 46 | $8,525 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,930 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,490 | $71 |
See all 6 services
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $24,563 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $13,888 | $107 |
| Return visit (30+ min) | 46 | $8,525 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,930 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,490 | $71 |
| Hemodialysis procedure with physician evaluation | 13 | $959 | $64 |
Who their Medicare patients are
139 Original Medicare patients in 2024. Average age 68 · Under 65 35% · 85 and older 9% · Women 38% · Also on Medicaid 89% · Health risk score 6.34. Sicker patients than 9 in 10 peers; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 73% · Heart failure 48% · Coronary heart disease 45% · Atrial fibrillation 32% · Depression 27% · Dementia 20% · Stroke 20% · COPD 17% · Cancer 11%.
The office billed $802,453, Medicare allowed $107,965 and paid $83,349; for 577 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 139 | 577 | 68 | 6.34 | $802,453 | $83,349 |
| 2023 | 161 | 642 | 67 | 6.36 | $840,814 | $86,636 |
| 2022 | 216 | 859 | 67 | 5.91 | $1,099,303 | $114,263 |
| 2021 | 181 | 788 | 66 | 6.04 | $1,017,358 | $106,480 |
| 2020 | 196 | 838 | 66 | 5.88 | $878,061 | $98,276 |
| 2019 | 233 | 924 | 66 | 6.04 | $722,001 | $105,586 |
| 2018 | 215 | 698 | 65 | 5.93 | $544,928 | $80,284 |
| 2017 | 196 | 628 | 67 | 6.03 | $512,921 | $74,868 |
| 2016 | 185 | 794 | 66 | 5.37 | $589,048 | $85,128 |
| 2015 | 266 | 975 | 63 | 5.59 | $763,127 | $108,353 |
| 2014 | 238 | 886 | 65 | 4.47 | $651,972 | $98,184 |
| 2013 | 267 | 936 | 64 | 4.86 | $759,000 | $108,268 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $26,251 | $184 |
| Home dialysis services per month (20 years or older) | 12 | $19,087 | $265 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $12,334 | $105 |
| Return visit (30+ min) | 48 | $9,300 | $85 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 11 | $6,830 | $273 |
| Dialysis procedure including 1 evaluation | 15 | $3,352 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,228 | $115 |
| Hemodialysis procedure with physician evaluation | 22 | $1,706 | $63 |
2022: 10 services
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $28,319 | $191 |
| Home dialysis services per month (20 years or older) | 13 | $24,332 | $270 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $20,295 | $94 |
| Return visit (30+ min) | 58 | $10,239 | $79 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $9,826 | $266 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,224 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,221 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,968 | $124 |
| Hemodialysis procedure with physician evaluation | 27 | $3,087 | $67 |
| Short return visit (20+ min) | 14 | $1,295 | $56 |
2021: 9 services
| Dialysis services, 1 physician visit per month (20 years or older) | 38 | $32,119 | $193 |
| Home dialysis services per month (20 years or older) | 12 | $21,616 | $277 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $18,539 | $277 |
| Return visit (30+ min) | 50 | $9,122 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,062 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $7,035 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,960 | $185 |
| Short return visit (20+ min) | 24 | $1,616 | $45 |
| Hemodialysis procedure with physician evaluation | 19 | $1,552 | $67 |
2020: 11 services
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $28,581 | $171 |
| Home dialysis services per month (20 years or older) | 12 | $18,374 | $224 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $13,325 | $218 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $12,680 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,665 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $4,810 | $68 |
| Return visit (30+ min) | 36 | $3,176 | $55 |
| Telephone medical discussion with physician, 11-20 minutes | 35 | $1,947 | $41 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $1,945 | $69 |
| Short return visit (20+ min) | 29 | $1,488 | $46 |
| Hemodialysis procedure with physician evaluation | 11 | $820 | $68 |
2019: 9 services
| Home dialysis services per month (20 years or older) | 16 | $20,500 | $216 |
| Dialysis services, 1 physician visit per month (20 years or older) | 46 | $20,179 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $15,532 | $95 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $12,615 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $12,338 | $181 |
| Return visit (30+ min) | 66 | $9,341 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $6,959 | $66 |
| Hemodialysis procedure with physician evaluation | 28 | $2,465 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,739 | $124 |
2018: 9 services
| Dialysis services, 1 physician visit per month (20 years or older) | 44 | $21,441 | $169 |
| Home dialysis services per month (20 years or older) | 11 | $10,589 | $208 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 16 | $10,096 | $215 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,498 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $9,175 | $94 |
| Return visit (30+ min) | 64 | $7,887 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $4,664 | $65 |
| Hemodialysis procedure with physician evaluation | 27 | $3,052 | $65 |
| New patient visit (60+ min) | 12 | $1,663 | $139 |
2017: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 50 | $26,687 | $167 |
| Home dialysis services per month (20 years or older) | 13 | $10,176 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $8,577 | $175 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $8,463 | $217 |
| Return visit (30+ min) | 54 | $6,820 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,949 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,827 | $64 |
| Hemodialysis procedure with physician evaluation | 16 | $1,479 | $64 |
2016: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 48 | $33,308 | $163 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $13,911 | $208 |
| Return visit (30+ min) | 67 | $10,506 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $5,408 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,537 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,022 | $64 |
| Hemodialysis procedure with physician evaluation | 22 | $1,746 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $430 | $7 |
2015: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 60 | $32,687 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $16,475 | $170 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $12,576 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $12,151 | $91 |
| Return visit (30+ min) | 69 | $10,167 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $9,343 | $63 |
| New patient visit (60+ min) | 14 | $1,793 | $128 |
| Hemodialysis procedure with physician evaluation | 21 | $1,571 | $63 |
2014: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 63 | $32,324 | $167 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 27 | $16,443 | $208 |
| Return visit (30+ min) | 87 | $13,716 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,847 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,702 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $5,083 | $92 |
| New patient visit (60+ min) | 22 | $3,020 | $137 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $352 | $6 |
2013: 10 services
| Dialysis services, 1 physician visit per month (20 years or older) | 54 | $28,065 | $160 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $26,652 | $207 |
| Home dialysis services per month (20 years or older) | 13 | $13,884 | $204 |
| Return visit (30+ min) | 70 | $9,597 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,585 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $7,502 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $5,740 | $90 |
| New patient visit (60+ min) | 26 | $3,457 | $133 |
| Long return visit (40+ min) | 21 | $1,598 | $61 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $259 | $6 |
Medicaid work
$2,755 in 2024
Medicaid paid $2,755 for 429 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 145 | $983 |
| Return visit (30+ min) | 182 | $753 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 76 | $730 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $220 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 12 | $69 |
| 2024 | 429 | 5 | 29 | $2,755 |
| 2023 | 635 | 5 | 39 | $5,950 |
| 2022 | 455 | 6 | 31 | $5,042 |
| 2021 | 508 | 5 | 28 | $8,134 |
| 2020 | 508 | 6 | 40 | $9,199 |
| 2019 | 785 | 8 | 37 | $12,048 |
| 2018 | 574 | 9 | 40 | $9,331 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 221 | $2,434 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 147 | $1,784 |
| Return visit (30+ min) | 228 | $1,388 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 25 | $344 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $0 |
2022
| Return visit (30+ min) | 108 | $2,038 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 220 | $1,134 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 14 | $619 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $476 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 41 | $387 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 45 | $387 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 142 | $3,627 |
| Return visit (30+ min) | 189 | $2,713 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $989 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 112 | $527 |
| 1ST HOSP IP/OBS HIGH 75 | 30 | $278 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 215 | $5,957 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 123 | $1,813 |
| Short return visit (20+ min) | 65 | $652 |
| Return visit (30+ min) | 60 | $403 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $268 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 18 | $106 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 217 | $4,779 |
| Return visit (30+ min) | 300 | $3,074 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 75 | $1,917 |
| 1ST HOSP IP/OBS HIGH 75 | 73 | $1,343 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 51 | $609 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 16 | $280 |
| OFF/OP EST MAY X REQ PHY/QHP | 16 | $48 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 37 | $0 |
2018
| Return visit (30+ min) | 271 | $3,206 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 78 | $2,921 |
| 1ST HOSP IP/OBS HIGH 75 | 69 | $913 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 28 | $667 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $559 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 57 | $498 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $328 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 12 | $191 |
| OFF/OP EST MAY X REQ PHY/QHP | 21 | $48 |
Drugs they prescribed that Part D paid
$604,108
Pharmacies billed $604,108 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,525) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
2,118 generic and 407 brand-name prescriptions · $604,108 in drug cost · 28 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 65 | $182,895 | $2,814 |
| Veltassa | 69 | $83,888 | $1,216 |
| Jardiance | 47 | $40,624 | $864 |
| Lokelma | 43 | $38,447 | $894 |
| Sevelamer Carbonate | 82 | $30,505 | $372 |
See all 44 drugs
| Velphoro | 65 | $182,895 | $2,814 |
| Veltassa | 69 | $83,888 | $1,216 |
| Jardiance | 47 | $40,624 | $864 |
| Lokelma | 43 | $38,447 | $894 |
| Sevelamer Carbonate | 82 | $30,505 | $372 |
| Cinacalcet | 61 | $21,133 | $346 |
| Lanthanum Carbonate | 15 | $13,656 | $910 |
| Prosol | 60 | $11,509 | $192 |
| Procrit | 13 | $11,022 | $848 |
| Sps | 57 | $7,433 | $130 |
| Calcium Acetate | 102 | $6,888 | $68 |
| Farxiga | 12 | $5,030 | $419 |
| Tacrolimus | 48 | $4,093 | $85 |
| Clonidine | 35 | $3,055 | $87 |
| Bumetanide | 58 | $2,767 | $48 |
| Febuxostat | 38 | $2,638 | $69 |
| Furosemide | 254 | $1,987 | $8 |
| Metolazone | 41 | $1,974 | $48 |
| Calcitriol | 85 | $1,052 | $12 |
| Losartan | 205 | $878 | $4 |
| Fosinopril | 32 | $718 | $22 |
| Gentamicin Sulfate | 31 | $692 | $22 |
| Hydralazine | 44 | $601 | $14 |
| Amlodipine Besylate | 255 | $545 | $2 |
| Isosorbide Dinitrate | 16 | $544 | $34 |
| Carvedilol | 73 | $503 | $7 |
| Metoprolol | 84 | $454 | $5 |
| Midodrine | 15 | $447 | $30 |
| Nystatin | 21 | $374 | $18 |
| Potassium Chloride | 24 | $373 | $16 |
| Metoprolol | 31 | $368 | $12 |
| Nifedipine Er | 29 | $308 | $11 |
| Atorvastatin | 72 | $292 | $4 |
| Prednisone | 49 | $215 | $4 |
| Doxazosin Mesylate | 23 | $165 | $7 |
| Allopurinol | 24 | $144 | $6 |
| Hydrochlorothiazide | 23 | $99 | $4 |
| Lisinopril | 25 | $72 | $3 |
| Gabapentin | 17 | $68 | $4 |
| Benazepril | 12 | $34 | $3 |
| Sertraline | 12 | $34 | $3 |
| Oxybutynin Chloride | 13 | $32 | $2 |
| Atenolol | 12 | $28 | $2 |
| Trazodone | 18 | $27 | $1 |
Year by year
| 2024 | 2,525 | 152 | 0% (0) | 16% | $604,108 |
| 2023 | 2,264 | 170 | 0% (0) | 17% | $682,666 |
| 2022 | 2,350 | 193 | 0% (0) | None | $590,142 |
| 2021 | 2,517 | 170 | 0% (0) | None | $410,799 |
| 2020 | 2,490 | 178 | None | None | $434,983 |
| 2019 | 2,266 | 185 | None | None | $432,334 |
| 2018 | 1,913 | 174 | None | None | $392,020 |
| 2017 | 2,346 | 207 | None | 28% | $593,770 |
| 2016 | 2,238 | 179 | None | None | $476,620 |
| 2015 | 2,263 | 196 | None | None | $420,856 |
| 2014 | 2,196 | 185 | None | None | $352,929 |
| 2013 | 1,818 | 161 | 1% (12) | None | $284,033 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 48 drugs
| Lupkynis | 12 | $149,312 | $12,443 |
| Renvela | 40 | $128,419 | $3,210 |
| Velphoro | 32 | $98,782 | $3,087 |
| Sevelamer Carbonate | 70 | $41,851 | $598 |
| Veltassa | 32 | $41,090 | $1,284 |
| Cinacalcet | 40 | $37,878 | $947 |
| Lokelma | 37 | $28,907 | $781 |
| Jardiance | 28 | $21,491 | $768 |
| Auryxia | 13 | $18,615 | $1,432 |
| Procrit | 12 | $13,258 | $1,105 |
| Lanthanum Carbonate | 11 | $11,009 | $1,001 |
| Calcium Acetate | 80 | $9,290 | $116 |
| Tacrolimus | 29 | $7,667 | $264 |
| Farxiga | 13 | $6,864 | $528 |
| Febuxostat | 32 | $5,424 | $169 |
| Sps | 37 | $5,325 | $144 |
| Bumetanide | 39 | $4,791 | $123 |
| Furosemide | 277 | $4,766 | $17 |
| Clonidine | 28 | $4,686 | $167 |
| Prosol | 41 | $4,173 | $102 |
| Amlodipine Besylate | 255 | $3,239 | $13 |
| Losartan | 177 | $3,181 | $18 |
| Mycophenolate Mofetil | 12 | $1,982 | $165 |
| Midodrine | 24 | $1,977 | $82 |
| Calcitriol | 68 | $1,492 | $22 |
| Fosinopril | 50 | $1,440 | $29 |
| Carvedilol | 86 | $1,403 | $16 |
| Atorvastatin | 59 | $1,354 | $23 |
| Metoprolol | 82 | $1,292 | $16 |
| Hydralazine | 55 | $1,207 | $22 |
| Doxazosin Mesylate | 31 | $940 | $30 |
| Gabapentin | 28 | $859 | $31 |
| Metolazone | 13 | $783 | $60 |
| Metoprolol | 44 | $711 | $16 |
| Isosorbide Dinitrate | 14 | $653 | $47 |
| Nifedipine Er | 31 | $644 | $21 |
| Potassium Chloride | 18 | $516 | $29 |
| Prednisone | 37 | $484 | $13 |
| Minoxidil | 14 | $417 | $30 |
| Gentamicin Sulfate | 13 | $411 | $32 |
| Benazepril | 28 | $365 | $13 |
| Allopurinol | 13 | $355 | $27 |
| Lisinopril | 15 | $345 | $23 |
| Tamsulosin | 14 | $256 | $18 |
| Famotidine | 13 | $255 | $20 |
| Metoclopramide | 12 | $189 | $16 |
| Atenolol | 16 | $102 | $6 |
| Sertraline | 12 | $34 | $3 |
2022: 42 drugs
| Renvela | 48 | $174,072 | $3,626 |
| Sevelamer Carbonate | 82 | $71,921 | $877 |
| Velphoro | 18 | $60,352 | $3,353 |
| Lokelma | 30 | $26,180 | $873 |
| Calcium Acetate | 115 | $22,844 | $199 |
| Tacrolimus | 67 | $15,560 | $232 |
| Auryxia | 13 | $14,387 | $1,107 |
| Sps | 63 | $14,220 | $226 |
| Procrit | 14 | $9,516 | $680 |
| Cinacalcet | 23 | $6,392 | $278 |
| Clonidine | 24 | $4,889 | $204 |
| Furosemide | 303 | $4,781 | $16 |
| Bumetanide | 22 | $3,584 | $163 |
| Amlodipine Besylate | 270 | $2,278 | $8 |
| Febuxostat | 12 | $2,119 | $177 |
| Metolazone | 18 | $1,912 | $106 |
| Calcitriol | 88 | $1,908 | $22 |
| Losartan | 173 | $1,759 | $10 |
| Hydralazine | 54 | $1,550 | $29 |
| Fosinopril | 55 | $1,453 | $26 |
| Mycophenolate Mofetil | 11 | $1,359 | $124 |
| Atorvastatin | 70 | $1,239 | $18 |
| Metoprolol | 116 | $1,221 | $11 |
| Potassium Chloride | 21 | $1,161 | $55 |
| Carvedilol | 60 | $1,034 | $17 |
| Gabapentin | 37 | $1,001 | $27 |
| Nifedipine Er | 28 | $951 | $34 |
| Doxazosin Mesylate | 48 | $783 | $16 |
| Midodrine | 22 | $680 | $31 |
| Gentamicin Sulfate | 14 | $621 | $44 |
| Metoprolol | 33 | $461 | $14 |
| Allopurinol | 23 | $402 | $17 |
| Nystatin | 12 | $399 | $33 |
| Famotidine | 27 | $355 | $13 |
| Metoclopramide | 19 | $273 | $14 |
| Prednisone | 28 | $255 | $9 |
| Lactulose | 14 | $201 | $14 |
| Simvastatin | 16 | $199 | $12 |
| Benazepril | 15 | $173 | $12 |
| Lisinopril | 25 | $165 | $7 |
| Heparin | 11 | $129 | $12 |
| Sertraline | 11 | $35 | $3 |
2021: 50 drugs
| Renvela | 35 | $119,408 | $3,412 |
| Sevelamer Carbonate | 92 | $38,349 | $417 |
| Auryxia | 29 | $34,942 | $1,205 |
| Sevelamer | 17 | $30,025 | $1,766 |
| Calcium Acetate | 131 | $22,145 | $169 |
| Veltassa | 12 | $16,211 | $1,351 |
| Tacrolimus | 54 | $14,196 | $263 |
| Procrit | 15 | $12,710 | $847 |
| Sps | 65 | $10,070 | $155 |
| Cinacalcet | 26 | $9,343 | $359 |
| Lokelma | 13 | $9,204 | $708 |
| Retacrit | 18 | $8,629 | $479 |
| Furosemide | 270 | $3,686 | $14 |
| Calcitriol | 133 | $3,025 | $23 |
| Prosol | 20 | $2,368 | $118 |
| Potassium Chloride | 49 | $2,229 | $45 |
| Amlodipine Besylate | 277 | $2,158 | $8 |
| Metolazone | 30 | $1,894 | $63 |
| Bumetanide | 19 | $1,870 | $98 |
| Mycophenolate Mofetil | 15 | $1,775 | $118 |
| Losartan | 149 | $1,534 | $10 |
| Hydralazine | 84 | $1,493 | $18 |
| Fosinopril | 63 | $1,343 | $21 |
| Clonidine | 13 | $1,246 | $96 |
| Carvedilol | 63 | $1,093 | $17 |
| Atorvastatin | 68 | $1,027 | $15 |
| Metoprolol | 106 | $1,020 | $10 |
| Sodium Polystyrene Sulfonate | 13 | $867 | $67 |
| Doxazosin Mesylate | 40 | $833 | $21 |
| Midodrine | 19 | $642 | $34 |
| Gentamicin Sulfate | 18 | $558 | $31 |
| Nystatin | 15 | $514 | $34 |
| Allopurinol | 32 | $479 | $15 |
| Gabapentin | 39 | $440 | $11 |
| Nifedipine Er | 14 | $428 | $31 |
| Prednisone | 37 | $409 | $11 |
| Loperamide | 16 | $398 | $25 |
| Metoprolol | 27 | $346 | $13 |
| Tamsulosin | 34 | $273 | $8 |
| Megestrol Acetate | 16 | $264 | $16 |
| Famotidine | 21 | $178 | $8 |
| Lisinopril | 18 | $155 | $9 |
| Fluticasone Propionate | 15 | $140 | $9 |
| Metoclopramide | 13 | $121 | $9 |
| Lactulose | 11 | $121 | $11 |
| Simvastatin | 13 | $117 | $9 |
| Benazepril | 15 | $107 | $7 |
| Trazodone | 11 | $93 | $8 |
| Heparin | 16 | $83 | $5 |
| Sertraline | 14 | $53 | $4 |
2020: 41 drugs
| Renvela | 63 | $181,952 | $2,888 |
| Cinacalcet | 40 | $39,701 | $993 |
| Veltassa | 32 | $31,472 | $984 |
| Sevelamer Carbonate | 98 | $27,573 | $281 |
| Calcium Acetate | 119 | $20,283 | $170 |
| Auryxia | 12 | $19,139 | $1,595 |
| Retacrit | 13 | $11,905 | $916 |
| Sps | 64 | $7,597 | $119 |
| Tacrolimus | 24 | $7,494 | $312 |
| Febuxostat | 16 | $5,959 | $372 |
| Calcitriol | 126 | $3,797 | $30 |
| Furosemide | 315 | $3,463 | $11 |
| Clonidine | 29 | $2,893 | $100 |
| Clinisol | 15 | $2,370 | $158 |
| Losartan | 146 | $1,683 | $12 |
| Hydralazine | 67 | $1,651 | $25 |
| Metolazone | 26 | $1,603 | $62 |
| Sodium Polystyrene Sulfonate | 13 | $1,575 | $121 |
| Potassium Chloride | 36 | $1,561 | $43 |
| Amlodipine Besylate | 289 | $1,458 | $5 |
| Mycophenolate Mofetil | 14 | $1,402 | $100 |
| Fosinopril | 56 | $1,030 | $18 |
| Metoprolol | 123 | $933 | $8 |
| Midodrine | 11 | $836 | $76 |
| Metoprolol | 37 | $724 | $20 |
| Atorvastatin | 56 | $656 | $12 |
| Carvedilol | 58 | $618 | $11 |
| Gentamicin Sulfate | 13 | $481 | $37 |
| Prednisone | 46 | $425 | $9 |
| Gabapentin | 40 | $408 | $10 |
| Nystatin | 12 | $401 | $33 |
| Tamsulosin | 45 | $341 | $8 |
| Fluocinonide | 16 | $317 | $20 |
| Allopurinol | 24 | $301 | $13 |
| Megestrol Acetate | 23 | $224 | $10 |
| Famotidine | 14 | $139 | $10 |
| Metoclopramide | 15 | $123 | $8 |
| Benazepril | 18 | $118 | $7 |
| Simvastatin | 20 | $113 | $6 |
| Trazodone | 18 | $98 | $5 |
| Heparin | 13 | $92 | $7 |
2019: 45 drugs
| Renvela | 67 | $193,089 | $2,882 |
| Sensipar | 21 | $31,961 | $1,522 |
| Sevelamer Carbonate | 59 | $31,917 | $541 |
| Veltassa | 34 | $27,405 | $806 |
| Velphoro | 11 | $19,132 | $1,739 |
| Cinacalcet | 15 | $14,433 | $962 |
| Calcium Acetate | 118 | $13,627 | $115 |
| Auryxia | 11 | $13,036 | $1,185 |
| Uloric | 18 | $10,745 | $597 |
| Furosemide | 364 | $3,882 | $11 |
| Calcitriol | 124 | $3,856 | $31 |
| Sps | 40 | $2,664 | $67 |
| Cyclosporine Modified | 11 | $2,357 | $214 |
| Tacrolimus | 22 | $2,271 | $103 |
| Clonidine | 14 | $1,930 | $138 |
| Metolazone | 21 | $1,810 | $86 |
| Hydralazine | 52 | $1,784 | $34 |
| Sodium Polystyrene Sulfonate | 20 | $1,455 | $73 |
| Amlodipine Besylate | 221 | $1,339 | $6 |
| Losartan | 139 | $1,327 | $10 |
| Fosinopril | 44 | $1,101 | $25 |
| Potassium Chloride | 32 | $1,010 | $32 |
| Nifedipine Er | 11 | $930 | $85 |
| Metoprolol | 30 | $794 | $26 |
| Gentamicin Sulfate | 17 | $779 | $46 |
| Atorvastatin | 47 | $753 | $16 |
| Metoprolol | 97 | $736 | $8 |
| Carvedilol | 55 | $653 | $12 |
| Gabapentin | 44 | $636 | $14 |
| Prednisone | 23 | $510 | $22 |
| Doxazosin Mesylate | 12 | $454 | $38 |
| Benazepril | 35 | $338 | $10 |
| Allopurinol | 15 | $278 | $19 |
| Tamsulosin | 33 | $258 | $8 |
| Pantoprazole | 21 | $238 | $11 |
| Valsartan | 12 | $172 | $14 |
| Lisinopril | 28 | $144 | $5 |
| Diltiazem | 17 | $144 | $8 |
| Simvastatin | 23 | $134 | $6 |
| Megestrol Acetate | 12 | $107 | $9 |
| Heparin | 15 | $102 | $7 |
| Sertraline | 16 | $89 | $6 |
| Trazodone | 16 | $64 | $4 |
| Metoclopramide | 13 | $54 | $4 |
| Ranitidine | 13 | $29 | $2 |
2018: 37 drugs
| Renvela | 79 | $198,266 | $2,510 |
| Velphoro | 15 | $32,489 | $2,166 |
| Sensipar | 12 | $30,699 | $2,558 |
| Sevelamer Carbonate | 23 | $28,363 | $1,233 |
| Veltassa | 17 | $13,722 | $807 |
| Calcium Acetate | 87 | $13,070 | $150 |
| Uloric | 17 | $10,490 | $617 |
| Creon | 12 | $6,294 | $524 |
| Calcitriol | 110 | $3,077 | $28 |
| Furosemide | 314 | $2,830 | $9 |
| Sodium Polystyrene Sulfonate | 32 | $2,809 | $88 |
| Sps | 14 | $2,035 | $145 |
| Clonidine | 16 | $1,980 | $124 |
| Potassium Chloride | 19 | $1,902 | $100 |
| Hydralazine | 56 | $1,832 | $33 |
| Losartan | 138 | $1,095 | $8 |
| Metoprolol | 44 | $1,087 | $25 |
| Fosinopril | 47 | $971 | $21 |
| Amlodipine Besylate | 193 | $956 | $5 |
| Labetalol | 17 | $807 | $47 |
| Gentamicin Sulfate | 14 | $716 | $51 |
| Nifedipine Er | 11 | $665 | $60 |
| Gabapentin | 39 | $589 | $15 |
| Metoprolol | 68 | $574 | $8 |
| Allopurinol | 29 | $528 | $18 |
| Atorvastatin | 34 | $466 | $14 |
| Benazepril | 49 | $398 | $8 |
| Tamsulosin | 29 | $381 | $13 |
| Prednisone | 21 | $329 | $16 |
| Isosorbide Mononitrate Er | 12 | $307 | $26 |
| Carvedilol | 41 | $275 | $7 |
| Valsartan | 13 | $194 | $15 |
| Diltiazem | 14 | $130 | $9 |
| Lisinopril | 19 | $126 | $7 |
| Pantoprazole | 14 | $86 | $6 |
| Simvastatin | 18 | $84 | $5 |
| Ranitidine | 17 | $43 | $3 |
2017: 43 drugs
| Renvela | 91 | $279,779 | $3,074 |
| Sensipar | 114 | $153,887 | $1,350 |
| Renagel | 19 | $32,584 | $1,715 |
| Calcium Acetate | 128 | $23,586 | $184 |
| Fosrenol | 12 | $11,587 | $966 |
| Veltassa | 15 | $10,391 | $693 |
| Uloric | 21 | $8,833 | $421 |
| Sodium Polystyrene Sulfonate | 43 | $3,389 | $79 |
| Kionex | 12 | $3,138 | $262 |
| Clonidine | 20 | $2,878 | $144 |
| Calcitriol | 116 | $2,786 | $24 |
| Furosemide | 383 | $2,561 | $7 |
| Tacrolimus | 20 | $2,350 | $117 |
| Labetalol | 18 | $1,314 | $73 |
| Amlodipine Besylate | 233 | $1,142 | $5 |
| Losartan | 129 | $988 | $8 |
| Hydralazine | 50 | $979 | $20 |
| Allopurinol | 49 | $951 | $19 |
| Potassium Chloride | 11 | $947 | $86 |
| Fosinopril | 55 | $938 | $17 |
| Gentamicin Sulfate | 15 | $891 | $59 |
| Valsartan | 21 | $797 | $38 |
| Metoprolol | 108 | $691 | $6 |
| Benazepril | 62 | $496 | $8 |
| Tamsulosin | 27 | $484 | $18 |
| Atorvastatin | 26 | $470 | $18 |
| Metolazone | 14 | $428 | $31 |
| Metoprolol | 23 | $406 | $18 |
| Nifedipine Er | 13 | $382 | $29 |
| Prednisone | 23 | $352 | $15 |
| Carvedilol | 27 | $268 | $10 |
| Isosorbide Mononitrate Er | 11 | $254 | $23 |
| Gabapentin | 27 | $236 | $9 |
| Omeprazole | 30 | $195 | $7 |
| Pantoprazole | 21 | $134 | $6 |
| Diltiazem | 14 | $130 | $9 |
| Simvastatin | 23 | $120 | $5 |
| Loperamide | 11 | $111 | $10 |
| Famotidine | 31 | $100 | $3 |
| Lisinopril | 21 | $91 | $4 |
| Trazodone | 12 | $49 | $4 |
| Ranitidine | 11 | $39 | $4 |
| Sertraline | 12 | $32 | $3 |
2016: 40 drugs
| Renvela | 107 | $255,268 | $2,386 |
| Sensipar | 90 | $73,517 | $817 |
| Renagel | 24 | $64,824 | $2,701 |
| Fosrenol | 12 | $17,412 | $1,451 |
| Calcium Acetate | 101 | $15,934 | $158 |
| Clonidine | 19 | $3,729 | $196 |
| Tacrolimus | 17 | $3,291 | $194 |
| Calcitriol | 104 | $2,487 | $24 |
| Cyclosporine Modified | 19 | $2,189 | $115 |
| Kionex | 28 | $2,131 | $76 |
| Sodium Polystyrene Sulfonate | 21 | $1,844 | $88 |
| Furosemide | 361 | $1,672 | $5 |
| Gentamicin Sulfate | 28 | $1,290 | $46 |
| Fosinopril | 73 | $1,112 | $15 |
| Allopurinol | 62 | $1,068 | $17 |
| Amlodipine Besylate | 220 | $1,050 | $5 |
| Mycophenolate Mofetil | 19 | $850 | $45 |
| Losartan | 108 | $838 | $8 |
| Labetalol | 17 | $785 | $46 |
| Metoprolol | 92 | $692 | $8 |
| Metolazone | 15 | $669 | $45 |
| Tamsulosin | 33 | $546 | $17 |
| Prednisone | 35 | $542 | $15 |
| Lidocaine-Prilocaine | 16 | $513 | $32 |
| Valsartan | 20 | $482 | $24 |
| Potassium Chloride | 14 | $439 | $31 |
| Hydralazine | 24 | $427 | $18 |
| Benazepril | 69 | $395 | $6 |
| Heparin | 29 | $352 | $12 |
| Famotidine | 40 | $297 | $7 |
| Simvastatin | 43 | $225 | $5 |
| Carvedilol | 21 | $197 | $9 |
| Omeprazole | 21 | $168 | $8 |
| Gabapentin | 24 | $168 | $7 |
| Clonidine | 13 | $158 | $12 |
| Spironolactone | 13 | $146 | $11 |
| Amiloride | 12 | $142 | $12 |
| Pantoprazole | 24 | $130 | $5 |
| Ranitidine | 18 | $128 | $7 |
| Sertraline | 17 | $93 | $5 |
2015: 38 drugs
| Renvela | 105 | $214,644 | $2,044 |
| Sensipar | 101 | $74,642 | $739 |
| Renagel | 22 | $47,418 | $2,155 |
| Calcium Acetate | 123 | $21,393 | $174 |
| Clonidine | 21 | $3,484 | $166 |
| Sodium Polystyrene Sulfonate | 21 | $3,163 | $151 |
| Calcitriol | 130 | $2,886 | $22 |
| Tacrolimus | 12 | $2,727 | $227 |
| Kionex | 24 | $2,611 | $109 |
| Cyclosporine Modified | 22 | $2,167 | $99 |
| Furosemide | 299 | $1,427 | $5 |
| Fosinopril | 99 | $1,415 | $14 |
| Amlodipine Besylate | 251 | $1,291 | $5 |
| Potassium Chloride | 32 | $1,076 | $34 |
| Labetalol | 21 | $938 | $45 |
| Gentamicin Sulfate | 23 | $807 | $35 |
| Metoprolol | 104 | $701 | $7 |
| Pravastatin | 19 | $663 | $35 |
| Mycophenolate Mofetil | 13 | $631 | $49 |
| Losartan | 72 | $627 | $9 |
| Hydralazine | 32 | $594 | $19 |
| Allopurinol | 49 | $574 | $12 |
| Benazepril | 65 | $494 | $8 |
| Nystatin | 15 | $491 | $33 |
| Famotidine | 55 | $441 | $8 |
| Tamsulosin | 22 | $362 | $16 |
| Simvastatin | 57 | $327 | $6 |
| Gabapentin | 48 | $306 | $6 |
| Valsartan | 15 | $293 | $20 |
| Prednisone | 20 | $281 | $14 |
| Heparin | 15 | $236 | $16 |
| Omeprazole | 17 | $197 | $12 |
| Clonidine | 21 | $147 | $7 |
| Metoprolol | 15 | $122 | $8 |
| Doxepin | 11 | $114 | $10 |
| Carvedilol | 13 | $91 | $7 |
| Sertraline | 11 | $61 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $15 | $1 |
2014: 42 drugs
| Renvela | 86 | $149,220 | $1,735 |
| Sensipar | 65 | $78,748 | $1,212 |
| Calcium Acetate | 109 | $20,379 | $187 |
| Renagel | 12 | $15,675 | $1,306 |
| Sevelamer Carbonate | 11 | $11,820 | $1,075 |
| Fosrenol | 13 | $10,045 | $773 |
| Kionex | 49 | $5,370 | $110 |
| Clonidine | 35 | $5,116 | $146 |
| Calcitriol | 131 | $4,519 | $34 |
| Tacrolimus | 16 | $3,855 | $241 |
| Diovan | 18 | $2,636 | $146 |
| Hydralazine | 68 | $1,888 | $28 |
| Fosinopril | 109 | $1,764 | $16 |
| Cyclosporine Modified | 15 | $1,685 | $112 |
| Nystatin | 33 | $1,397 | $42 |
| Amlodipine Besylate | 207 | $1,258 | $6 |
| Furosemide | 191 | $1,241 | $6 |
| Gentamicin Sulfate | 30 | $1,171 | $39 |
| Mycophenolate Mofetil | 15 | $1,004 | $67 |
| Metoprolol | 145 | $920 | $6 |
| Pravastatin | 36 | $856 | $24 |
| Labetalol | 23 | $811 | $35 |
| Losartan | 81 | $736 | $9 |
| Benazepril | 75 | $642 | $9 |
| Potassium Chloride | 14 | $628 | $45 |
| Bumetanide | 12 | $455 | $38 |
| Heparin | 21 | $378 | $18 |
| Atorvastatin | 23 | $364 | $16 |
| Gabapentin | 57 | $359 | $6 |
| Tamsulosin | 16 | $327 | $20 |
| Doxazosin Mesylate | 12 | $299 | $25 |
| Simvastatin | 47 | $290 | $6 |
| Clonidine | 25 | $259 | $10 |
| Metoprolol | 15 | $245 | $16 |
| Omeprazole | 21 | $223 | $11 |
| Ranitidine | 24 | $191 | $8 |
| Allopurinol | 40 | $182 | $5 |
| Famotidine | 26 | $146 | $6 |
| Lactulose | 14 | $129 | $9 |
| Lisinopril | 16 | $108 | $7 |
| Carvedilol | 11 | $71 | $6 |
| Alendronate | 11 | $49 | $4 |
2013: 37 drugs
| Renvela | 80 | $122,715 | $1,534 |
| Sensipar | 63 | $65,518 | $1,040 |
| Calcium Acetate | 89 | $19,231 | $216 |
| Tacrolimus | 23 | $7,685 | $334 |
| Kionex | 64 | $4,777 | $75 |
| Calcitriol | 105 | $4,273 | $41 |
| Clonidine | 14 | $1,533 | $109 |
| Fosinopril | 70 | $1,302 | $19 |
| Amlodipine Besylate | 153 | $1,248 | $8 |
| Furosemide | 153 | $1,165 | $8 |
| Diovan | 12 | $1,161 | $97 |
| Hydralazine | 41 | $1,160 | $28 |
| Mycophenolate Mofetil | 16 | $1,153 | $72 |
| Labetalol | 14 | $1,119 | $80 |
| Cyclosporine Modified | 12 | $911 | $76 |
| Nystatin | 27 | $911 | $34 |
| Losartan | 42 | $831 | $20 |
| Metoprolol | 88 | $736 | $8 |
| Gentamicin Sulfate | 31 | $662 | $21 |
| Benazepril | 61 | $619 | $10 |
| Gabapentin | 62 | $586 | $9 |
| Heparin | 26 | $487 | $19 |
| Pravastatin | 32 | $435 | $14 |
| Atorvastatin | 17 | $398 | $23 |
| Clonidine | 39 | $258 | $7 |
| Ranitidine | 32 | $254 | $8 |
| Simvastatin | 24 | $249 | $10 |
| Omeprazole | 12 | $192 | $16 |
| Allopurinol | 37 | $181 | $5 |
| Carvedilol | 22 | $178 | $8 |
| Doxazosin Mesylate | 12 | $159 | $13 |
| Metoprolol | 11 | $148 | $13 |
| Zolpidem | 21 | $103 | $5 |
| Famotidine | 11 | $71 | $6 |
| Sulfamethoxazole-Trimethoprim | 14 | $69 | $5 |
| Alendronate | 11 | $65 | $6 |
| Prednisone | 12 | $61 | $5 |
Money from drug and device companies
$41,459 in 2025
| 2025 | 4 | 57 | $30,280 | $41,459 |
| 2024 | 2 | 42 | $18,606 | $32,245 |
| 2023 | 2 | 25 | $10,499 | $29,854 |
| 2022 | 2 | 31 | $15,292 | $18,335 |
| 2021 | 2 | 12 | $9,395 | $9,395 |
| 2020 | 2 | 10 | $13,430 | $13,430 |
| 2019 | 2 | 39 | $19,330 | $24,065 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vantive US Healthcare | Renal - Acute | $36,076 | 49 payments
|
| Fresenius USA Manufacturing | None | $3,780 | 3 payments
|
| Baxter Healthcare | Renal - Acute | $1,503 | 4 payments
|
| NxStage Medical | Liberty Select Cycler | $100 | 1 payment
|
See all 57 published payments
| Vantive US Healthcare | Consulting · 2025-12-18 | Renal - Acute | $750 |
| Vantive US Healthcare | Consulting · 2025-12-18 | Renal - Acute | $750 |
| Vantive US Healthcare | Consulting · 2025-11-27 | Renal - Acute | $844 |
| Vantive US Healthcare | Consulting · 2025-11-27 | Renal - Acute | $1,219 |
| Vantive US Healthcare | Consulting · 2025-11-20 | Renal - Acute | $2,063 |
| Vantive US Healthcare | Travel · 2025-11-19 | Renal - Acute | $346 |
| Vantive US Healthcare | Meals · 2025-11-19 | Renal - Acute | $40 |
| Vantive US Healthcare | Consulting · 2025-11-13 | Renal - Acute | $2,250 |
| Vantive US Healthcare | Consulting · 2025-11-13 | Renal - Acute | $1,500 |
| Vantive US Healthcare | Meals · 2025-11-12 | Renal - Acute | $7 |
| Fresenius USA Manufacturing | Paid to speak or teach · 2025-11-12 | None | $1,050 |
| Vantive US Healthcare | Consulting · 2025-10-30 | Renal - Acute | $1,500 |
| Vantive US Healthcare | Meals · 2025-10-15 | Renal - Pd | $22 |
| Vantive US Healthcare | Consulting · 2025-10-14 | Renal - Acute | $1,500 |
| Vantive US Healthcare | Travel · 2025-10-14 | Renal - Acute | $273 |
| Vantive US Healthcare | Meals · 2025-10-14 | Renal - Pd | $132 |
| Vantive US Healthcare | Meals · 2025-10-14 | Renal - Pd | $51 |
| Vantive US Healthcare | Travel · 2025-10-13 | Renal - Acute | $202 |
| Vantive US Healthcare | Meals · 2025-10-13 | Renal - Pd | $44 |
| NxStage Medical | Meals · 2025-08-28 | Liberty Select Cycler | $100 |
| Vantive US Healthcare | Travel · 2025-07-10 | Renal - Chronic | $49 |
| Vantive US Healthcare | Meals · 2025-07-10 | Renal - Chronic | $66 |
| Vantive US Healthcare | Education · 2025-07-10 | Renal - Chronic | $5,438 |
| Vantive US Healthcare | Consulting · 2025-06-26 | Renal - Acute | $656 |
| Vantive US Healthcare | Consulting · 2025-06-11 | Renal - Acute | $1,500 |
| Vantive US Healthcare | Consulting · 2025-06-05 | Renal - Acute | $750 |
| Vantive US Healthcare | Consulting · 2025-05-22 | Renal - Acute | $375 |
| Vantive US Healthcare | Meals · 2025-05-16 | Renal - Chronic | $27 |
| Vantive US Healthcare | Meals · 2025-05-16 | Renal - Chronic | $13 |
| Vantive US Healthcare | Travel · 2025-05-15 | Renal - Chronic | $304 |
| Vantive US Healthcare | Meals · 2025-05-15 | Renal - Chronic | $27 |
| Vantive US Healthcare | Meals · 2025-05-15 | Renal - Chronic | $30 |
| Vantive US Healthcare | Meals · 2025-05-15 | Renal - Chronic | $14 |
| Vantive US Healthcare | Meals · 2025-05-15 | Renal - Chronic | $15 |
| Fresenius USA Manufacturing | Paid to speak or teach · 2025-05-15 | None | $1,500 |
| Fresenius USA Manufacturing | Paid to speak or teach · 2025-05-14 | None | $1,230 |
| Vantive US Healthcare | Travel · 2025-05-13 | Renal - Chronic | $348 |
| Vantive US Healthcare | Meals · 2025-04-07 | Renal - Acute | $77 |
| Vantive US Healthcare | Travel · 2025-04-07 | Renal - Acute | $106 |
| Vantive US Healthcare | Meals · 2025-04-07 | Renal - Acute | $50 |
| Vantive US Healthcare | Travel · 2025-04-07 | Renal - Acute | $76 |
| Vantive US Healthcare | Travel · 2025-04-07 | Renal - Acute | $46 |
| Vantive US Healthcare | Consulting · 2025-04-07 | Renal - Acute | $4,281 |
| Vantive US Healthcare | Travel · 2025-04-07 | Renal - Acute | $536 |
| Vantive US Healthcare | Travel · 2025-04-07 | Renal - Acute | $226 |
| Vantive US Healthcare | Meals · 2025-04-07 | Renal - Acute | $8 |
| Vantive US Healthcare | Travel · 2025-04-01 | Renal - Chronic | $586 |
| Vantive US Healthcare | Travel · 2025-02-13 | Renal - Acute | $214 |
| Vantive US Healthcare | Consulting · 2025-02-13 | Renal - Acute | $3,188 |
| Vantive US Healthcare | Meals · 2025-02-13 | Renal - Acute | $58 |
| Vantive US Healthcare | Travel · 2025-02-06 | Renal - Acute | $119 |
| Vantive US Healthcare | Meals · 2025-02-06 | Renal - Acute | $23 |
| Vantive US Healthcare | Consulting · 2025-02-06 | Renal - Acute | $3,375 |
| Baxter Healthcare | Meals · 2025-01-18 | Renal - Acute | $72 |
| Baxter Healthcare | Travel · 2025-01-18 | Renal - Acute | $331 |
| Baxter Healthcare | Meals · 2025-01-17 | Renal - Acute | $150 |
| Baxter Healthcare | Travel · 2025-01-17 | Renal - Acute | $950 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $32,245
| Baxter Healthcare | Renal - Pd | $29,695 | 41 payments
|
| Akebia Therapeutics | Vafseo | $2,550 | 1 payment
|
2023: $29,854
| Baxter Healthcare | Renal - Pd | $29,840 | 24 payments
|
| Calliditas Therapeutics US | Tarpeyo | $14 | 1 payment
|
2022: $18,335
| Fresenius USA Marketing | None | $9,889 | 9 payments
|
| Baxter Healthcare | Renal - Pd | $8,446 | 22 payments
|
2021: $9,395
| Fresenius USA Marketing | Velphoro | $5,213 | 5 payments
|
| Baxter Healthcare | Renal - Pd | $4,182 | 7 payments
|
2020: $13,430
| Fresenius USA Marketing | Cyclers | $7,650 | 4 payments
|
| Baxter Healthcare | Renal - Pd | $5,780 | 6 payments
|
2019: $24,065
| Fresenius USA Marketing | None | $18,814 | 32 payments
|
| Baxter Healthcare | Renal - Pd | $5,251 | 7 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1164527826
- Licence
- CA A67175California A67175: Current · expires 2028-12-31
- Trained
- Wake Forest University School of Medicine, 1997
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A671750
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-09-14
- NPI last updated
- 2007-09-12
This is when the NPI record was last certified, not a medical board exam.